Cantor Fitzgerald analyst Steven Halper noted that Health Insurance Innovations shares are trading higher, which he presumes to be in response to the White House Office of Information and Regulatory Affairs having concluded its review of President Trump's executive order to roll back the time limit for short-term medical plans to 364 days from 90 days. While the company was mostly able to work around the existing rule, he believes the move back to 364-day plans will positively impact demand for short-term medical plans, Halper tells investors. He keeps an Overweight rating and $60 price target on Health Insurance Innovations shares.